According to ChainCatcher, the founder of VitaDAO, a decentralized autonomous organization that aims to fund longevity research projects, has launched a new protocol called BIO, which aims to allow the global community of patients, scientists, and biotechnology developers to jointly provide financial support for the development and commercialization of new therapies. The protocol raises funds through a decentralized autonomous organization (DAO) and uses the funds from token sales to support related biotechnology projects, thereby sharing intellectual property rights. BIO raised $6.2 million through public sales in the first token generation event (TGE), with participants including venture capital institutions such as Zee Prime and 1kx. Details of the second round of TGE will be announced soon.